戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 albumin, another protein purified from human seminal plasma.
2 emoved inhibitory factors sometimes found in seminal plasma.
3 translational modifications (PTMs) in bovine seminal plasma.
4 ar to the inhibition previously described in seminal plasma.
5 immunodeficiency virus type 1 (HIV-1) RNA in seminal plasma.
6  as by a partially purified protease(s) from seminal plasma.
7 P94), another major protein component in the seminal plasma.
8 ctive role of spermine, a major component of seminal plasma.
9 utathione peroxidase [GPx]) were measured in seminal plasma.
10 talization, and viral diversity in blood and seminal plasma.
11 s for the quantitation of HIV RNA in CSF and seminal plasma.
12  in part, enhancement of bacterial growth by seminal plasma.
13 ivation status did not change in response to seminal plasma.
14 is acquired as the result of exposure to the seminal plasma.
15 ction persisted when HSV-2 was introduced in seminal plasma.
16 had at least 1 herpesvirus detected in their seminal plasma.
17 ed by real-time polymerase chain reaction in seminal plasma.
18 entage can be significantly suppressed under seminal plasma.
19 ng principal aspects of the Ect1 response to seminal plasma.
20 s simplex virus type 2 (HSV-2) introduced in seminal plasma.
21 plasma lipid levels, and HIV-1 RNA levels in seminal plasma.
22  in blood plasma (4.24 log(10) copies/mL) or seminal plasma (3.55 log(10) copies/mL; P<.05, each comp
23 idespread detection of organic pollutants in seminal plasma across all exposure classes.
24 IV-1 infection and inhibition in whole human seminal plasma and a synthetic simulant that we formulat
25                                       Median seminal plasma and blood plasma HIV-1 RNA concentrations
26 und DOR concentrations were observed in both seminal plasma and cervicovaginal fluid.
27  in these assays are typically purified from seminal plasma and contain many molecular forms (intact
28 quenced such a nuclease isolated from bovine seminal plasma and identified human, rat and mouse homol
29   CRISP3 is an abundant protein of the human seminal plasma and interacts with alpha-1-B glycoprotein
30   CRISP3 is an abundant protein of the human seminal plasma and interacts with prostate secretory pro
31        However, the unstable nature of human seminal plasma and its toxic effects on cells in culture
32  histopathological variables, sperm quality, seminal plasma and plasma oxidative stress, seminal plas
33          Elevated levels of cytokines in the seminal plasma and prostatic secretions have been detect
34 nd lamivudine achieve high concentrations in seminal plasma and significantly reduce HIV-1 RNA.
35              Understanding of the impacts of seminal plasma and sperm proteins on both animal and hum
36 udy, we characterized for the first time the seminal plasma and sperm proteomes of the critically end
37 e to the immunosuppressive activity of human seminal plasma and to the low immunogenicity of sperm.
38 od plasma were compared to those detected in seminal plasma and/or cerebral spinal fluid of six indiv
39  pathways including blood clotting cascades (seminal plasma) and both actin dynamics and immune pathw
40 a1, TGF-beta2, and TGF-beta3 are abundant in seminal plasma, and Affymetrix microarray revealed that
41 ebrospinal fluid (CSF), saliva, breast milk, seminal plasma, and cervical-vaginal lavage fluid (CVL).
42 ample to remove white blood cells, wash away seminal plasma, and reduce sample volume.
43 le removing white blood cells, replacing the seminal plasma, and reducing the volume of the sample to
44 LOC609402 and LOC100685620 (AGP) proteins in seminal plasma, and significantly reduced expression of
45                        We detected VEGF-C in seminal plasma, and sperm liquefaction occurred concurre
46 253 (5%) cervicovaginal lavages, 20/322 (6%) seminal plasmas, and 6/85 (7%) rectal secretions.
47 ociated with higher HIV-1 loads in blood and seminal plasma; and (5) CMV seminal reactivation increas
48      Infection and inhibition in whole human seminal plasma are accurately mimicked by a stable synth
49 that they retain activity in the presence of seminal plasma are indicated.
50  synthases and secreted by the prostate into seminal plasma are thought to support reproduction, but
51  of differentially expressed proteins in the seminal plasma as diagnostic biomarker for primary and s
52       BPSA purified from prostate tissue and seminal plasma, as well as BPSA generated in vitro by mi
53 ecimens can be used as external controls for seminal plasma assays.
54 However, 8 men (27%) had measurable HIV-1 in seminal plasma at their last study visit, 4 with increas
55       Most men (77%) had HIV-1 RNA levels in seminal plasma below the limit of quantification during
56 ived from either NPD or LPD sperm (devoid of seminal plasma) but in the presence of NPD or LPD semina
57               A fraction isolated from llama seminal plasma by column chromatography was identified a
58                 Quantitation of HIV-1 RNA in seminal plasma can be reliably accomplished using two co
59    In multivariate analysis, the presence of seminal plasma CMV (P = 0.04), detectable 2-long termina
60                                          The seminal plasma compartment was more dynamic than the blo
61 h an eightfold increase in virus load in the seminal plasma compartment.
62 ee viral populations in the blood plasma and seminal plasma compartments of men infected with subtype
63                                              Seminal plasma competitively inhibited binding of the mi
64                  Median lamivudine blood and seminal plasma concentrations were 391.3 (range, 175.3-7
65 (25th-75th percentiles) zidovudine blood and seminal plasma concentrations were 64.2 (range, 48.4-206
66      Western blot analysis of llama and bull seminal plasma confirmed immunorecognition of OIF using
67 the possibility that endometrial exposure to seminal plasma could contribute to endometriotic disease
68                           Standardization of seminal plasma derived PSA calibrant molecular form mass
69 al plasma) but in the presence of NPD or LPD seminal plasma (devoid of sperm).
70           Several other cytokines present in seminal plasma did not elicit Ect1 cell responses.
71 nocytes in the presence of high dilutions of seminal plasma did not express CD1a but showed high leve
72 uspension matrices that used blood plasma or seminal plasma did not make a difference in recovery of
73 h urethritis had HIV-1 RNA concentrations in seminal plasma eight times higher than those in seroposi
74                                 Pooled human seminal plasma enhanced E. coli growth in vitro in a dos
75                      These data suggest that seminal plasma enhances the formation of endometriosis-l
76                                              Seminal plasma EVs (SP-EVs) were isolated and characteri
77   The non-sperm part of ejaculated semen, or seminal plasma, facilitates the delivery of sperm to the
78 lipid levels; and no detectable HIV-1 RNA in seminal plasma from all 8 participants tested.
79                                  Exposure to seminal plasma from HIV-1-infected and uninfected men wi
80                                              Seminal plasma from llamas and bulls was used as represe
81 nducted to characterize proteomic profile of seminal plasma from men with primary, or secondary infer
82 tion fluid derived from epididymal flush and seminal plasma from the prostate and seminal vesicle was
83 ion fluid generated from epididymal flush or seminal plasma from ZIKV infected males at 14 and 35 DPI
84                              This is a human seminal plasma glycoprotein that is immunologically indi
85 efore therapy, 4 men had HIV-1 RNA levels in seminal plasma &gt;6.0 log10 (1 million) copies/mL, markedl
86 nce of an ovulation-inducing factor (OIF) in seminal plasma has broad implications and evokes questio
87           There was no significant change in seminal plasma HIV-1 RNA concentrations during the 2-wee
88         CD4 cell counts and blood plasma and seminal plasma human immunodeficiency virus type 1 (HIV-
89                                              Seminal plasma immunocaptures yielded amplifiable virion
90 ressed HIV-1 RNA levels to <400 copies/mL in seminal plasma in the majority of patients, the first di
91 lored the relationship of HIV-1 in blood and seminal plasma in the presence and absence of urethritis
92 ed to examine organic chemical pollutants in seminal plasma, including both known priority environmen
93 ntagonists, and signaling inhibitors ablated seminal plasma induction of GM-CSF and IL-6, but did not
94                                We found that seminal plasma interfered with the activity of PRO 2000
95                                              Seminal plasma is a critical and complex fluid that carr
96                                   Given that seminal plasma is an abundant source of transforming gro
97                      We conclude that OIF in seminal plasma is beta-NGF and that it is highly conserv
98                                              Seminal plasma is not just a carrier for spermatozoa.
99 is unknown which compounds in spermatozoa or seminal plasma may be involved in the regulation of sper
100   By promoting a tolerogenic profile in DCs, seminal plasma might favor fertility, but might also com
101 ral blood mononuclear cells (PBMCs; n = 72), seminal plasma (n = 20), cerebrospinal fluid (CSF; n = 3
102 detectable (<400 copies/mL) in the blood and seminal plasma of 8/9 subjects after initiation of thera
103  autoantibody responses were detected in the seminal plasma of infertile patients, suggesting conserv
104                                          The seminal plasma of some species with internal fertilizati
105 beta, we evaluated the effect of exposure to seminal plasma on the growth of endometrial lesions.
106  prevented the tolerogenic effect induced by seminal plasma on the phenotype and function of DCs, sug
107 nsmitted viruses were evident in the donor's seminal plasma (one of five cases) and even more so in t
108   Human endometrial explants were exposed to seminal plasma or to control medium before transfer to P
109                 HIV-1 RNA from blood plasma, seminal plasma, or cervical wicks was quantified at base
110 = 0.09) and more frequent shedding of CMV in seminal plasma (p = 0.002).
111 ce were protected if virus was introduced in seminal plasma (P=.0007, log rank test).
112 ed that %ViableSperm of bulls was related to seminal plasma peroxiredoxin-5, spermadhesin-1 and the s
113  Our results elucidate a mechanism whereby a seminal plasma pheromone attracts ready-to-mate females
114  83% were blood plasma positive and 63% were seminal plasma positive.
115             However, other forms of inactive seminal plasma prostate-specific antigen, either intact
116 have a role in the physiologic processing of seminal plasma proteins such as pro-PSA, as well as in t
117 This report is the largest dataset of bovine seminal plasma proteins.
118           The present study investigated the seminal plasma proteome of Holstein bulls with low (LF;
119                                  Proteome of seminal plasma provides profound information related to
120                                 To this end, seminal plasma purified PSA standards from different com
121 measured in log(10) RNA copies/milliliter of seminal plasma) ranging from 0.11 to 0.32; those of the
122                  In this study, we show that seminal plasma redirects the differentiation of human de
123 iologically relevant events, the addition of seminal plasma resulted in enhanced virion binding to ep
124                In addition, HIV-1 virions in seminal plasma samples harbored dramatically higher leve
125 with paired blood plasma and CVL, saliva, or seminal plasma samples revealed 91% were blood plasma po
126       When HIV-1 virions were incubated with seminal plasma samples, infectivity in initially nondivi
127 .05) elevation in high grade prostate cancer seminal plasma samples.
128   Sperm characteristics, oxidative stress of seminal plasma, serum and sperm membrane fatty acids, di
129                        Xenografts exposed to seminal plasma showed an eightfold increase in volume an
130                    HIV-1 RNA was measured in seminal plasma (SP) and blood plasma (BP) at baseline, o
131 hieving first undetectable HIV-1 RNA (VL) in seminal plasma (SP) and blood plasma (BP) in 19 men star
132  weeks post-switch, we measured HIV-1 RNA in seminal plasma (SP) and blood plasma (BP), tenofovir (TF
133                              Decay of HIV in seminal plasma (SP) and rectal fluid (RF) has not yet be
134               Antiretroviral pharmacology in seminal plasma (SP) and rectal tissue (RT) may provide i
135  accelerated dramatically in the presence of seminal plasma (SP) and that agitation is not required f
136                                   Therefore, seminal plasma (SP) collected from healthy individuals w
137 triple therapy donated blood plasma (BP) and seminal plasma (SP) during therapy.
138  and SF162 after incubation with centrifuged seminal plasma (SP) from HIV-negative donors and assesse
139 c concentrations of antiretroviral agents in seminal plasma (SP) may reduce virus burden and influenc
140 etroviral drug families on viral kinetics in seminal plasma (SP) of treatment-naive HIV-infected pati
141 f the intrinsic anti-HIV-1 activity of human seminal plasma (SP) was determined to reside in the cati
142 red (LOQ 40 copies/mL) in blood plasma (BP), seminal plasma (SP), rectal fluid (RF), and cervicovagin
143 ication, 40 copies/mL) in blood plasma (BP), seminal plasma (SP), rectal fluid (RF), and cervicovagin
144 oncentrations were measured in blood plasma, seminal plasma (SP), rectal tissue (RT), and cervicovagi
145                                              Seminal plasma (SP), the liquid portion of semen, harbor
146 h may facilitate HIV transmission.IMPORTANCE Seminal plasma (SP), the major vehicle for HIV, can modu
147 and of the transmembrane C regulator CD46 in seminal plasma (SP).
148 nd cardiovascular function in a sperm and/or seminal plasma specific manner.
149  paternal low protein diet in a sperm and/or seminal plasma specific manner.
150 rdiovascular function through both sperm and seminal plasma specific mechanisms over successive gener
151 ascular homeostasis and define the sperm and seminal plasma specific programming effects on cardiovas
152                    HIV-RNA was quantified in seminal plasma (spVL) and in blood plasma (bpVL) from 2
153                                              Seminal plasma stimulated the production of a variety of
154  = .002), despite a more sensitive assay for seminal plasma than for cervical wicks.
155 lls were used to investigate agents in human seminal plasma that induce a proinflammatory response.
156 all three TGF-beta isoforms as key agents in seminal plasma that signal induction of proinflammatory
157 ganic pollutant exposures were measured from seminal plasma using gas chromatography, which showed wi
158 mplified from cell-free HIV RNA in blood and seminal plasma using the MiSeq Illumina platform.
159 he HIV-1 RNA viral loads was observed in the seminal plasma values than in the blood plasma values wh
160 All macaques were systemically infected, and seminal plasma virion-associated RNA (vRNA) levels were
161  seminal plasma and plasma oxidative stress, seminal plasma vitamin E, and plasma testosterone levels
162                                   Absence of seminal plasma was accompanied by down-regulation of the
163                                              Seminal plasma was assayed for HIV-1 RNA and semen was c
164            The concentration of HIV-1 RNA in seminal plasma was monitored as a potential surrogate ma
165 os developed in female tracts not exposed to seminal plasma were abnormal from the early cleavage sta
166 dine, lamivudine, and HIV-1 RNA in blood and seminal plasma were measured in 9 HIV-positive men over
167               Viral loads in whole semen and seminal plasma were strongly correlated with blood plasm
168 ml (range, <400 to 2.8 x 10(5) copies/ml) in seminal plasma, which is 10- to 1,000-fold higher than p

 
Page Top